BEAM
#1695
Beam Therapeutics Inc. - Common Stock
30.4 8 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.96%
Variación mensual
+16.38%
Variación en los últimos 6 meses
+11.28%
Cambio anual
+80.68%
Cierres anteriores
30.1 9
Open
30.4 8
Mínimo
30.4 8
Máximo
30.4 8
Volumen
133
Financials
- Market Capitalization 3.15 B
- Employee 540
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-34.22
Relación precio/flujo de caja
19.62
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1688 |  IRON Disc Medicine, Inc. - Common Stock | 82.55 USD | -0.15% | +3.84% | +10.86% | +37.93% | 3.17 B USD | ||
| 1694 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.92 USD | +1.80% | +0.28% | +22.40% | +8.87% | 3.16 B USD | ||
| 1701 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.87 USD | -1.07% | -2.43% | -11.84% | +60.14% | 3.13 B USD | ||
| 1716 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 15.21 USD | +10.78% | +12.09% | +51.49% | +680.00% | 3.07 B USD |